Saving Women’s Lives
The Sahel suffers from the highest maternal mortality rates globally–the leading cause of which is hemorrhage after childbirth. OASIS focuses on high-impact, scalable solutions, like integration of the WHO essential medicine, misoprostol, to prevent and treat hemorrhage after childbirth. We work with governments and implementing partners to integrate misoprostol alongside important maternal health goals, such as increased use of prenatal care, facility births, postpartum family planning, and access to life-saving post-abortion care.
Saving Women’s Lives in Chad
OASIS is partnering with the Ministry of Health and Prevention (Ministère de la Santé Publique et de la Prévention) in Chad to integrate misoprostol for postpartum hemorrhage prevention and treatment into the public health care system down to the community level. Activities include updating the national maternal health guidelines to ensure they correspond with the most recent World Health Organization recommendations, working with the regulatory authority and central medical stores to ensure high-quality misoprostol availability in the public sector, training providers from referral hospitals down to community-level health workers, and re-enforcing monitoring and evaluation practices to reduce potential barriers to availability. OASIS uses a multi-stakeholder model, which is comprised of local actors (government agencies, non-government organizations) and supported by multi-laterals and international non-government organizations.